Unilever Ventures Joins Nutrafol as Lead Investor for Nutraceutical Hair Loss Brand

Tuesday, May 09, 2017 | Business of Medicine , Personnel/Company News , Product Launches and Updates


Nutrafol, a nutraceutical supplement for healthy hair growth for men and women, has closed its series A financing round. Unilever Ventures, the venture-capital and private-equity arm of consumer packaged goods conglomerate, joins as lead investor after an initial introduction from investment platform CircleUp.

Nutrafol is a science-based research and development company focused on formulating hair health solutions.  Nutrafol products for men and women are available through multiple channels including physicians, salons and online. The company, committed to providing natural, healthy and effective solutions for hair loss and poor hair health, challenged the science behind conventional hair loss solutions. In 2015 they teamed up with world-renowned hair loss experts in the field of dermatology and integrative healthcare to develop a nutraceutical hair growth supplement composed of clinically-tested ingredients.

“Up until now, physicians have had very few, if any, healthy options to offer patients concerned with poor hair health,” says Nutrafol’s president, Roland Peralta. “Our researchers created an award-winning solution that fills the void by providing the medical community a healthy and effective option, without side effects, for their patients in the treatment of poor hair health.”

“By leveraging the latest discoveries in hair research and biotechnology, we reverse engineered a formulation to target many underlying causes of hair loss, which our competitors fail to address,” remarks Giorgos Tsetis, C.E., the CEO of Nutrafol.

“Hair loss is a global issue affecting millions of men and women every day. The founding team at Nutrafol, a nutraceutical supplement, has done a phenomenal job disrupting the status quo of the hair loss industry by shifting the paradigm in how western medicine talks about hair loss,” says Stephen Willson, Investment Director, Unilever Ventures. “Consumers are demanding natural solutions that work- the high trajectory growth of the brand is indicative that Nutrafol is on the frontier of that.”

Investment from Unilever Ventures, along with other strategic partners, will be used by Nutrafol to progress scientific research, product development and drive growth in the medical, salon, and e-commerce channels. For more information visit www.nutrafol.com.

Next Story

Comments

You must be logged in to leave a comment.